These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 23564302)

  • 1. Hepatic cirrhosis secondary to nonalcoholic fatty liver disease in a 12-year-old girl with morbid obesity.
    Sharma A; Freese DK; Chandan V; Zarroug AE; Swain JM; Kumar S
    Clin Pediatr (Phila); 2014 Jan; 53(1):86-8. PubMed ID: 23564302
    [No Abstract]   [Full Text] [Related]  

  • 2. Nonalcoholic fatty liver disease and bariatric surgery in adolescents.
    Holterman A; Gurria J; Tanpure S; DiSomma N
    Semin Pediatr Surg; 2014 Feb; 23(1):49-57. PubMed ID: 24491369
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pediatric nonalcoholic fatty liver disease.
    Bozic MA; Subbarao G; Molleston JP
    Nutr Clin Pract; 2013 Aug; 28(4):448-58. PubMed ID: 23917437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validation of noninvasive biomarkers (FibroTest, SteatoTest, and NashTest) for prediction of liver injury in patients with morbid obesity.
    Lassailly G; Caiazzo R; Hollebecque A; Buob D; Leteurtre E; Arnalsteen L; Louvet A; Pigeyre M; Raverdy V; Verkindt H; Six MF; Eberle C; Patrice A; Dharancy S; Romon M; Pattou F; Mathurin P
    Eur J Gastroenterol Hepatol; 2011 Jun; 23(6):499-506. PubMed ID: 21499110
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Lesions of the liver in patients with alimentary-constitutional morbid obesity].
    Romanov MM; Kuzin NM; Lebedev SP; Markov VK; Rodina LF; Brimas GE
    Klin Med (Mosk); 1989 Nov; 67(11):14-20. PubMed ID: 2696832
    [No Abstract]   [Full Text] [Related]  

  • 6. [Obesity: risk factor for steatohepatitis and hepatic fibrosis].
    Poniachik J; Mancilla C; Contreras J; Csendes A; Smok G; Cavada G; Rojas J; Oksenberg D; Burdiles P; Maluenda F; Díaz JC
    Rev Med Chil; 2002 Jul; 130(7):731-6. PubMed ID: 12235896
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nonalcoholic fatty liver disease in individuals with severe obesity.
    Haynes P; Liangpunsakul S; Chalasani N
    Clin Liver Dis; 2004 Aug; 8(3):535-47, viii. PubMed ID: 15331062
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nonalcoholic fatty liver disease in pediatric patients.
    Sinatra FR
    JPEN J Parenter Enteral Nutr; 2012 Jan; 36(1 Suppl):43S-8S. PubMed ID: 22237875
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fatty liver disease in morbid obesity.
    Clain DJ; Lefkowitch JH
    Gastroenterol Clin North Am; 1987 Jun; 16(2):239-52. PubMed ID: 3319904
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Nonalcoholic fatty liver hepatitis and fatty cirrhosis mimicking alcoholic liver diseases].
    Spech HJ; Liehr H; Mitschke H
    Z Gastroenterol; 1983 Nov; 21(11):651-9. PubMed ID: 6659631
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Should nonalcoholic fatty liver be considered precirrhotic?].
    Massarrat S; Asholt K; Schmitz-Moormann P
    Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():543-6. PubMed ID: 612027
    [No Abstract]   [Full Text] [Related]  

  • 12. Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis.
    Angulo P; Keach JC; Batts KP; Lindor KD
    Hepatology; 1999 Dec; 30(6):1356-62. PubMed ID: 10573511
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Nonalcoholic steatohepatitis].
    da Silva PM; Eliseu T; Costa MM; Bastos H; Nobre FL
    Acta Med Port; 1995 May; 8(5):323-7. PubMed ID: 7625233
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A combination of the pediatric NAFLD fibrosis index and enhanced liver fibrosis test identifies children with fibrosis.
    Alkhouri N; Carter-Kent C; Lopez R; Rosenberg WM; Pinzani M; Bedogni G; Feldstein AE; Nobili V
    Clin Gastroenterol Hepatol; 2011 Feb; 9(2):150-5. PubMed ID: 20888433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of bariatric surgery on nonalcoholic fatty liver disease.
    de Freitas AC; Campos AC; Coelho JC
    Curr Opin Clin Nutr Metab Care; 2008 May; 11(3):267-74. PubMed ID: 18403923
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Steatohepatic cirrhosis in a morbidly obese patient].
    Kohan M; López D; Botto G; Alessio C
    Acta Gastroenterol Latinoam; 1999; 29(4):271-5. PubMed ID: 10599403
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors of nonalcoholic steatohepatitis and advanced fibrosis in morbidly obese patients.
    Ong JP; Elariny H; Collantes R; Younoszai A; Chandhoke V; Reines HD; Goodman Z; Younossi ZM
    Obes Surg; 2005 Mar; 15(3):310-5. PubMed ID: 15826462
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatic histopathology of morbid obesity: concurrence of other forms of chronic liver disease.
    Liew PL; Lee WJ; Lee YC; Wang HH; Wang W; Lin YC
    Obes Surg; 2006 Dec; 16(12):1584-93. PubMed ID: 17217634
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ruptured hepatocellular carcinoma in a patient with nonalcoholic steatohepatitis.
    Smith BM; Hussain A; Jacobs M; Merrick HW
    Surg Obes Relat Dis; 2009; 5(4):510-2. PubMed ID: 19342313
    [No Abstract]   [Full Text] [Related]  

  • 20. [Nonalcoholic steatohepatitis: diagnosis, pathogenesis, treatment and prognosis].
    Jansen PL
    Ned Tijdschr Geneeskd; 2005 Feb; 149(6):289-94. PubMed ID: 15730035
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.